Cefixime

头孢克肟

Report date: 2026/04/21 20:00:18
NME

Base Information

Drug NameCefixime
Drug Alias Name头孢克肟世伏素CefiximaCefiximum世福素氨噻肟烯头孢菌素 +[15] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics > Third-generation cephalosporins
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsAcute BronchitisCystitisUrethritis +[20] 
Global Approved IndicationsAcute BronchitisCystitisUrethritis +[19] 
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryJapan
Original Approved Date1987/06/30
Country/TerritoryUnited StatesSouth AfricaMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesNihon GenericGuangzhou Baiyunshan Pharmaceutical Co Ltd Guangzhou Baiyunshan Pharmaceutical General
Inactive CompaniesGlaxosmithkline PlcB. Lederle GmbhNational Institute Of Allergy And Infectious Diseases (Niaid) +[4] 
Active IndicationsAcute BronchitisCystitisUrethritis +[11] 
Inactive IndicationsRespiratory Tract DiseasesUrinary Tract InfectionsTonsillitis +[9] 

Other Information

ATC CodeJ01DD08
Related LinksWikipediaDrugBankKEGG